A recent analysis of adverse drug reactions by Indian Pharmacopoeia Commission revealed that combinations of beta-blockers ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

New international consensus guidelines were developed through a research method, known as a Delphi process, that used a ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

National DRESS Syndrome Day 2025 Highlights "Faces of DRESS" to Advocate for Urgent Scientific Investment RICHMOND, Va., July 2, 2025 /PRNewswire/ -- In ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...